Expression of Basic Fibroblast Growth Factor, Vascular Endothelial Growth Factor, and Thrombospondin‐1 Related to Microvessel Density in Nonaggressive and Aggressive Basal Cell Carcinomas
暂无分享,去创建一个
You-Sun Kim | K. Kwon | C. Oh | H. Jang | Y. Kwon
[1] N. Sheibani. Thrombospondin‐1, PECAM‐1, and Regulation of Angiogenesis , 2006, Histology and histopathology.
[2] R. K. Bright,et al. Thrombospondin‐1 expression and clinical implications in malignant pleural mesothelioma , 1999, Cancer.
[3] N. Fusenig,et al. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] David W. Dawson,et al. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.
[6] K. Yanagisawa,et al. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. , 1996, Cancer research.
[7] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[8] D. Roberts,et al. Regulation of tumor growth and metastasis by thrombospondin‐1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] G. de Rosa,et al. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. , 1996, Human pathology.
[10] A. Anichini,et al. Interaction with fibronectin regulates cytokine gene expression in human melanoma cells , 1996, International journal of cancer.
[11] Yasuhiko Hayashi,et al. Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.
[12] A. Eisen,et al. Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. , 1995, The Journal of investigative dermatology.
[13] R. Kerbel,et al. Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. , 1994, The American journal of pathology.
[14] W Blumenfeld,et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.
[15] A. Lee,et al. Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.
[16] D. Macdonald,et al. Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell‐derived tumours , 1991, Journal of cutaneous pathology.
[17] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[18] D. Jones,et al. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.
[19] J. Wolf,et al. Tumor angiogenic factor and human skin tumors. , 1975, Archives of dermatology.
[20] S. Nishiyama. [CAPILLARY DEMONSTRATION BY ALKALINE PHOSPHATASE STAINING IN DIFFERENT DERMATOSES. VI. EPITHELIAL TUMORS]. , 1964, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[21] D. Moscatelli,et al. The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.